Devices › Device types
FDA product code MAX · class 2 · Orthopedic
Intervertebral fusion device with bone graft, lumbar: medical device reports filed with FDA
9,238 reports carry this product code, 1996–2026; 21 brands with a page.
- 9,238
- reports with this product code
- 0% of all MAUDE reports
- 695
- reports, 12 months to August 2026
- 865 in the 12 months before
- 63.3%
- classified as malfunction
- 62.3% across all reports
- 0.3%
- classified as death, as reported
- 0.9% across all reports
Product code MAX is FDA's classification for "Intervertebral fusion device with bone graft, lumbar" (orthopedic panel), a class 2 device. 9,238 medical device reports carry this product code, 0% of the MAUDE database, from January 1996 to August 2026.
695 reports arrived in the 12 months to August 2026, down 20% from 865 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (63.3%), injury (35.6%) and other (0.5%). 21 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Catalyft PL Expandable Interbody System | 376 | 95 | 0% | 74.9% |
| ELEVATE Spinal System | 322 | 46 | 0% | 88.9% |
| CAPSTONE Spinal System | 321 | 26 | 0.3% | 46.1% |
| Crescent Spinal System | 305 | 5 | 0.6% | 82.3% |
| Clydesdale Spinal System | 234 | 33 | 0.4% | 53.1% |
| CLYDESDALE PTC Spinal System | 222 | 5 | 0% | 77.9% |
| Pivox Oblique Lateral Spinal System | 221 | 5 | 0% | 80% |
| T-Pal Spacer Applicator Inner Shaft | 187 | 0 | 0% | 88.6% |
| T-Pal Spacer Applicator Knob | 139 | 0 | 0% | 86.5% |
| T-Pal Spacer Applicator Handle | 93 | 0 | 0% | 86% |
| Unknown Cage/Spacer | 29 | 4 | 0% | 6.4% |
| Unknown_Spine_Product | 29 | 24 | 0% | 34.4% |
| Orthopedic Manual Surgical Instrument | 19 | 0 | 0.2% | 85.9% |
| Collect No Qas Spine Anterior Stabilis | 7 | 0 | 0% | 2.2% |
| Verte-Stack Spinal System | 4 | 0 | 0.5% | 63.2% |
| Divergence Anterior Cervical Fusion System | 3 | 30 | 0% | 93% |
| Ti Matrix Locking Cap | 3 | 0 | 1.2% | 15.3% |
| Locking Screw | 2 | 3 | 0% | 17.8% |
| Unknown Implant | 2 | 1,454 | 0% | 1.2% |
| Onyx | 1 | 69 | 13.4% | 12% |
| Tsrh Spinal System | 1 | 0 | 0.4% | 23.4% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Medtronic Sofamor Danek USA | 815 | 8.8% |
| Mdt Sofamor Danek Puerto Rico Mfg | 484 | 5.2% |
| Nuvasive | 450 | 4.9% |
| Warsaw Orthopedics | 433 | 4.7% |
| Stryker Spine-US | 375 | 4.1% |
| K2m | 283 | 3.1% |
| Depuy Spine | 230 | 2.5% |
| Stryker Spine-France | 220 | 2.4% |
| Medtronic Sofamor Danek | 198 | 2.1% |
| Medos International S Rl Ch | 185 | 2% |
| Synthes Hagendorf | 177 | 1.9% |
| Zimmer Biomet Spine | 172 | 1.9% |
| Zimmer Spine | 155 | 1.7% |
| Medtronic Navigation | 131 | 1.4% |
| Ldr M Dical | 119 | 1.3% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Breakthe device broke | 2,650 | 28.7% |
| Migrationthe device moved from where it was placed | 784 | 8.5% |
| Fracturea broken bone | 783 | 8.5% |
| Migration or expulsion of device | 624 | 6.8% |
| Mechanical problema mechanical problem | 528 | 5.7% |
| Device-device incompatibility | 442 | 4.8% |
| Collapse | 208 | 2.3% |
| Material deformation | 203 | 2.2% |
| Device dislodged or dislocated | 190 | 2.1% |
| Insufficient device problem information | 185 | 2% |
| Material integrity problema problem with the device material | 180 | 1.9% |
| Device operates differently than expectedthe device behaved unexpectedly | 177 | 1.9% |
| Mechanical jam | 166 | 1.8% |
| Compatibility problem | 136 | 1.5% |
| Crackthe device cracked | 130 | 1.4% |
| Detachment of device component | 129 | 1.4% |
| Mechanics altered | 120 | 1.3% |
| Difficult to insertthe device was hard to insert | 116 | 1.3% |
| Malposition of device | 116 | 1.3% |
| Material fragmentation | 103 | 1.1% |
Questions about intervertebral fusion device with bone graft, lumbar reports
What is product code MAX?
FDA's classification code for "Intervertebral fusion device with bone graft, lumbar", class 2, reviewed by the orthopedic panel. Every device report carries the product code of the device involved.
How many reports carry this code?
9,238 reports through August 2026, 695 of them in the latest 12 months.
Which brands appear most often?
Catalyft PL Expandable Interbody System (376), ELEVATE Spinal System (322), CAPSTONE Spinal System (321), Crescent Spinal System (305) and Clydesdale Spinal System (234). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.